
Niramaya Med-Formulations Private Limite D
Founded in 2005 and headquartered in Delhi, India.
Founded in 2005 and headquartered in Delhi, India.
East Delhi, Delhi, India
+91-XXXXXXXXXX
U24232DL2005PTC139233
139233
Private Limited Indian Non-Government Company
02 Aug 2005
30 Sep 2011
31 Mar 2011
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mukesh Jain ![]() | Director | 02-Aug-2005 | Current |
Krishan Goyal ![]() | Director | 02-Aug-2005 | Current |
Enhance accessibility to Niramaya Med-Formulations Limite D's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Niramaya Med-Formulations Limite D's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Mukesh Jain is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Niramaya Med-Formulations Limite D, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Niramaya Med-Formulations Limite D, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niramaya Med-Formulations Limite D's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Niramaya Med-Formulations Private Limite D last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records.
Niramaya Med-Formulations Private Limite D has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Delhi.
Mukesh Kumar Jain was appointed as a Director was appointed as a Director on 02 Aug 2005 & has been associated with this company since 19 years 7 months .
Krishan Kumar Goyal was appointed as a Director was appointed as a Director on 02 Aug 2005 & has been associated with this company since 19 years 7 months .
Niramaya Med-Formulations Private Limite D was registered on 02 Aug 2005 with Roc Delhi & aged 19 years 7 months as per MCA records.
Niramaya Med-Formulations Private Limite D was incorporated on 02 Aug 2005.
The authorized share capital of Niramaya Med-Formulations Private Limite D is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Niramaya Med-Formulations Private Limite D.
As per Ministry of Corporate Affairs (Mca), the registered address of Niramaya Med-Formulations Private Limite D is U-196 Upadhaya Blockvikas Marg Shakarpur Mkt, New Delhi East Delhi, India, 110092.
The corporate identification number (CIN) of Niramaya Med-Formulations Private Limite D is U24232DL2005PTC139233 and the company number is 139233 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Niramaya Med-Formulations Private Limite D was filed with the ROC on 31 Mar 2011.